Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in DRTS — Alpha Tau Medical Ltd.

CIK 1214717 BOSTON, MA
Back to DRTS Full portfolio

Position in DRTS

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$671,759
+$294,229 QoQ
Shares Held
53,399
0.0% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 74 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DRTS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. DRTS ranks #345 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in DRTS

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $671,759 53,399
2026-03-31 $377,530 53,399
2025-12-31 $187,570 37,893
2025-09-30 $170,897 37,893
2025-06-30 $118,226 37,893
2025-03-31 $95,111 37,893
2024-12-31 $117,468 37,893
2024-09-30 $85,004 35,716
2024-06-30 $90,361 35,716
2024-03-31 $105,362 35,716
2023-12-31 $107,505 35,716
2023-09-30 $135,363 35,716
2023-06-30 $144,542 33,076
2023-03-31 $76,359 26,606
2022-12-31 $64,369 20,242
2022-09-30 $118,213 20,242
2022-06-30 $182,380 20,242